Company Number: SC662328

Analysis Date: 2025-07-20 15:10 UTC

Financial Health Assessment Report for BECRUX LTD

---

1. Financial Health Score: D (At Risk)

Explanation:
BECRUX LTD shows persistent net current liabilities and negative net assets over the last four years, indicating a fragile financial position. The company is struggling to maintain healthy working capital and equity levels, which signals financial distress symptoms that require prompt attention.

---

2. Key Vital Signs

Metric	Latest (2024)	Interpretation
Current Assets	£0	No liquid or short-term assets available
Current Liabilities	£90	Small short-term debts exist
Net Current Assets	-£90	Negative working capital; liabilities exceed assets
Net Assets (Shareholders’ Funds)	-£90	Company equity is negative, indicating insolvency risk
Share Capital	£100	Minimal paid-in capital
Number of Employees	Nil	No employees, possibly lean operation or inactive workforce

Interpretation of Vital Signs:

• Negative Net Current Assets (working capital): The company does not have enough short-term assets to meet short-term debts, a critical symptom of liquidity distress.
• Negative Net Assets: This reflects that total liabilities exceed total assets, often a red flag for solvency issues.
• Minimal Share Capital: Low equity base limits financial resilience.
• No Employees: Could indicate very limited business operations or reliance on external contractors.

---

3. Diagnosis

BECRUX LTD is displaying clear symptoms of financial distress:

• Liquidity Weakness: Persistent negative net current assets indicate the company’s cash and other short-term assets are insufficient to cover immediate liabilities. The "healthy cash flow" needed to cover operational costs is absent or severely compromised.
• Insolvency Warning: Negative net assets over multiple years suggest the business is "under the weather" financially, with liabilities outweighing assets. This is a sign that the company may struggle to meet long-term obligations without intervention.
• Lack of Business Growth Indicators: No employees and minimal capital injection hint at a stagnant or very small-scale operation, which limits the company’s capacity to improve its financial position organically.
• Micro-Entity Status: While filing under micro-entity provisions reduces compliance burdens, it also means less detailed financial data is available, making in-depth diagnosis challenging. However, the available figures clearly show a need for remedial action.

---

4. Recommendations

To nurse the company back to financial health and avoid more severe outcomes like insolvency or forced liquidation, the following measures are advised:

• Improve Liquidity:

  • Inject additional capital or arrange short-term financing to cover liabilities and create positive working capital.
  • Review and manage creditors to possibly negotiate extended payment terms.
  • Accelerate receivables collection or inject cash to increase current assets.

• Strengthen Equity Base:

  • Consider a shareholder capital increase or external investment to restore positive net assets.
  • Explore grants or government support programs available for small businesses.

• Operational Review:

  • Assess business model viability given the lack of employees and minimal assets.
  • Explore partnerships, outsourcing, or restructuring to improve operational efficiency and revenue generation.

• Financial Monitoring and Reporting:

  • Establish regular cash flow forecasting to detect early warning signs of distress.
  • Maintain transparent and timely financial records to enable swift decision-making.

• Professional Advice:

  • Engage financial advisors or insolvency practitioners early for guidance on restructuring options, if required.

---

Summary

BECRUX LTD is currently facing liquidity and solvency challenges, evidenced by consistent negative net current assets and net liabilities. Without intervention, the company risks worsening financial health. Immediate steps to improve working capital and strengthen equity are crucial to restore stability and ensure ongoing viability.